Overactivation of S6 Kinase 1 as a Cause of Human Insulin Resistance During Increased Amino Acid Availability
- 1 September 2005
- journal article
- Published by American Diabetes Association in Diabetes
- Vol. 54 (9), 2674-2684
- https://doi.org/10.2337/diabetes.54.9.2674
Abstract
To examine the molecular mechanisms by which plasma amino acid elevation impairs insulin action, we studied seven healthy men twice in random order during infusion of an amino acid mixture or saline (total plasma amino acid ∼6 vs. ∼2 mmol/l). Somatostatin-insulin-glucose clamps created conditions of low peripheral hyperinsulinemia (∼100 pmol/l, 0–180 min) and prandial-like peripheral hyperinsulinemia (∼430 pmol/l, 180–360 min). At low peripheral hyperinsulinemia, endogenous glucose production (EGP) did not change during amino acid infusion but decreased by ∼70% during saline infusion (EGP150–180 min 11 ± 1 vs. 3 ± 1 μmol · kg−1 · min−1, P = 0.001). Prandial-like peripheral hyperinsulinemia completely suppressed EGP during both protocols, whereas whole-body rate of glucose disappearance (Rd) was ∼33% lower during amino acid infusion (Rd330–360 min 50 ± 4 vs. 75 ± 6 μmol · kg−1 · min−1, P = 0.002) indicating insulin resistance. In skeletal muscle biopsies taken before and after prandial-like peripheral hyperinsulinemia, plasma amino acid elevation markedly increased the ability of insulin to activate S6 kinase 1 compared with saline infusion (∼3.7- vs. ∼1.9-fold over baseline). Furthermore, amino acid infusion increased the inhibitory insulin receptor substrate-1 phosphorylation at Ser312 and Ser636/639 and decreased insulin-induced phosphoinositide 3-kinase activity. However, plasma amino acid elevation failed to reduce insulin-induced Akt/protein kinase B and glycogen synthase kinase 3α phosphorylation. In conclusion, amino acids impair 1) insulin-mediated suppression of glucose production and 2) insulin-stimulated glucose disposal in skeletal muscle. Our results suggest that overactivation of the mammalian target of rapamycin/S6 kinase 1 pathway and inhibitory serine phosphorylation of insulin receptor substrate-1 underlie the impairment of insulin action in amino acid–infused humans.Keywords
This publication has 45 references indexed in Scilit:
- Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivityNature, 2004
- Processed meat intake and incidence of Type 2 diabetes in younger and middle-aged womenDiabetologia, 2003
- Increased plasma levels of plasminogen activator inhibitor-1 and soluble vascular cell adhesion molecule after triacylglycerol infusion in manThrombosis and Haemostasis, 2003
- Free Fatty Acids Inhibit the Glucose-Stimulated Increase of Intramuscular Glucose-6-Phosphate Concentration in HumansJournal of Clinical Endocrinology & Metabolism, 2001
- Specificity and mechanism of action of some commonly used protein kinase inhibitorsBiochemical Journal, 2000
- Bidirectional modulation of insulin action by amino acids.JCI Insight, 1998
- Regulation of Rat Glucagon Receptor ExpressionBiochemical and Biophysical Research Communications, 1994
- Quantitation of Muscle Glycogen Synthesis in Normal Subjects and Subjects with Non-Insulin-Dependent Diabetes by13C Nuclear Magnetic Resonance SpectroscopyNew England Journal of Medicine, 1990
- Metabolism of forearm tissues in man. Studies with glucagonDiabetes, 1976
- Stimulation of insulin secretion by amino acids.JCI Insight, 1966